Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Propofol - Generic Drug Details

« Back to Dashboard

What are the generic sources for propofol and what is the scope of propofol freedom to operate?

is the generic ingredient in two branded drugs marketed by Sagent Pharms, Watson Labs Inc, Hospira, Fresenius Kabi Usa, West-ward Pharms Int, and Teva Parenteral, and is included in six NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for propofol. Six suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: propofol

Drug Master File Entries: see list12
Suppliers / Packagers: see list6
Bulk Api Vendors: see list76
Clinical Trials: see list388
Patent Applications: see list4,252
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:propofol at DailyMed

Pharmacology for Ingredient: propofol

Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia

Tentative approvals for PROPOFOL

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe10MG/MLINJECTABLE; INJECTION
► Subscribe► Subscribe10MG/MLINJECTABLE; INJECTION
► Subscribe► Subscribe10MG/MLINJECTABLE; INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
INJECTABLE;INJECTION074848-001Apr 19, 2005DISCNNoNo► Subscribe► Subscribe
Watson Labs Inc
INJECTABLE;INJECTION205307-001Dec 22, 2015ABRXNoNo► Subscribe► Subscribe
Teva Parenteral
INJECTABLE;INJECTION075392-001Sep 19, 2000DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
INJECTABLE;INJECTION019627-001Oct 2, 1989DISCNNoNo► Subscribe► Subscribe
INJECTABLE;INJECTION077908-001Mar 17, 2006ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus